Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Priscilla K. Brastianos, MD
Massachusetts General Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
106 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Palo Alto Medical Foundation-Sunnyvale
Sunnyvale, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Vacaville
Vacaville, California, United States
- Sutter Solano Medical Center/cancer Center
Vallejo, California, United States
- Smilow Cancer Center/yale-New Haven Hospital
New Haven, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Smilow Cancer Hospital Care Center-Trumbull
Trumbull, Connecticut, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
- Idaho Urologic Institute-Meridian
Meridian, Idaho, United States
- Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
- Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Central Care Cancer Center - Garden City
Garden City, Kansas, United States
- Central Care Cancer Center - Great Bend
Great Bend, Kansas, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Bronson Battle Creek
Battle Creek, Michigan, United States
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
Grand Rapids, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jan 2018
- Primary completion
- 22 Sept 2023
- Completion
- 1 Aug 2028
- Last update posted
- 10 Jun 2026
- Registered enrollment
- 24
- Registry id
- NCT03224767
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.